Wimmer Katharina, Decker Mathias, Mayatepek Ertan, Beiglböck Harald, Eggermann Thomas, Kehrer-Sawatzki Hildegard, Fonatsch Christa, Rosenbaum Thorsten
Department of Human Genetics, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Austria.
Pediatr Res. 2005 Dec;58(6):1265-8. doi: 10.1203/01.pdr.0000183661.81772.f8.
Mutations in the NF1 gene (17q11.2) cause neurofibromatosis type 1 (NF1), a pleiotropic and progressive autosomal dominant disorder with marked variability of clinical expression. Clinical diagnosis is usually readily achieved in most adult and adolescent patients due to the presence of at least two of the classic signs of NF1. However, the absence of many of the disease-defining features in young children frequently renders definite diagnosis impossible in this age group. Particularly, clinical diagnosis is challenging in young patients whose phenotypical presentation does not lie within the common spectrum of "typical" NF1 features. Sensitive and reliable molecular genetic testing can be of great help in these cases. Here, we report clinical and molecular findings in a 2-year-old boy with features of NF1. Severe growth retardation together with other dysmorphic features was also suggestive for Silver-Russell syndrome (SRS) in this patient. Molecular genetic testing identified a novel NF1 mutation and, thus, enabled a confident NF1 diagnosis despite the unusual phenotypical presentation in this patient.
NF1基因(17q11.2)突变导致1型神经纤维瘤病(NF1),这是一种多效性、进行性常染色体显性疾病,临床表现具有显著变异性。由于大多数成年和青少年患者至少存在两种NF1的典型体征,临床诊断通常很容易实现。然而,幼儿缺乏许多疾病的特征性表现,这使得该年龄组的明确诊断往往无法进行。特别是,对于那些表型表现不在“典型”NF1特征常见范围内的年轻患者,临床诊断具有挑战性。在这些情况下,灵敏可靠的分子遗传学检测可能会有很大帮助。在此,我们报告了一名具有NF1特征的2岁男孩的临床和分子学发现。该患者严重生长发育迟缓以及其他畸形特征也提示患有Silver-Russell综合征(SRS)。分子遗传学检测鉴定出一种新的NF1突变,因此,尽管该患者的表型表现不寻常,但仍能做出可靠的NF1诊断。